Chubb Group of Insurance Companies Releases New Online Insurance System
A new online system from the Chubb Group of Insurance Companies aims to help life sciences companies obtain clinical trial liability insurance documentation more quickly and easily. The new system, Chubb WORLDcert, allows drug and medical device developers to secure required insurance documentation for clinical trials around the globe.
Life science companies and contract research organizations can find it difficult to secure approval from a medical institution’s ethics committee to begin a clinical trial without accurate documentation that appropriate insurance has been secured.
WORLDcert provides instant certificates of insurance in 149 countries. Sponsors of clinical trials in these countries generally will be able to receive certificates without having to wait for an insurance agent or broker.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
